uurimisrühmad - Stabilis 4.0

viimane versioon :
19/11/2024

uurimisrühmad - Pharmaceutical Research and Development, Pfizer Inc

pdf

Ameerika ühendriigid

farmaatsialaboratoorium

Pharmaceutical Research and Development, Pfizer Inc

Andover

Email

Viited

Viited

(2)

1

Physicochemical stability of PF-05280014 (trastuzumab-qyyp; TrazimeraTM), a trastuzumab biosimilar, under extended in-use conditions.
Weiser S, Burns C, Zartler E (Sarah.Weiser@pfizer.com)
J Oncol Pharm Practice - 2023 - ;29,3:

2

Physicochemical stability of PF-06439535 (bevacizumab-bvzr; Zirabev®), a bevacizumab biosimilar, under extended in-use conditions.
Weiser S, Burns C, Zartler E. (Sarah.Weiser@pfizer.com)
J Oncol Pharm Practice - 2022 - ;29, 5: 1032-1043

ingredientide nimekiri

molekulid uuritud

(2)

		Bevacizumab
		Trastuzumab

Mentions Légales